BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ATP2B3, PMCA3, 492, ENSG00000067842
71 results:

  • 1. Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
    Scilipoti P; Rosiello G; Larcher A; Fallara G; Cignoli D; Re C; Musso G; Cei F; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
    World J Urol; 2024 Apr; 42(1):264. PubMed ID: 38676733
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Risk factors for massive hemorrhage after radical nephrectomy and removal of venous tumor thrombus].
    Lan D; Liu Z; Li YX; Wang GL; Tian XJ; Ma LL; Zhang SD; Zhang HX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):825-832. PubMed ID: 37807735
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinicopathologic features and prognosis of young renal tumors with tumor thrombus].
    Xue ZX; Tang SY; Qiu M; Liu C; Tian XJ; Lu M; Dong JH; Ma LL; Zhang SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):802-811. PubMed ID: 37807732
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.
    Kobayashi M; Numakura K; Hatakeyama S; Ishida T; Koizumi A; Tadachi K; Igarashi R; Takayama K; Muto Y; Sekine Y; Sobu R; Sasagawa H; Akashi H; Kashima S; Yamamoto R; Nara T; Saito M; Narita S; Ohyama C; Habuchi T
    Int J Clin Oncol; 2023 Nov; 28(11):1530-1537. PubMed ID: 37552353
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development and External Validation of Machine Learning-Based Models for Predicting Lung Metastasis in kidney Cancer: A Large Population-Based Study.
    Yi X; Zhang Y; Cai J; Hu Y; Wen K; Xie P; Yin N; Zhou X; Luo H
    Int J Clin Pract; 2023; 2023():8001899. PubMed ID: 37383704
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of renal and hepatic function on first opioid prescriptions in cancer patients: an acute care hospital database study linked to medical claims data and laboratory data.
    Takahashi R; Miyashita M; Oba MS; Murakami Y
    Jpn J Clin Oncol; 2023 Aug; 53(9):823-828. PubMed ID: 37282610
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of an Immune Prognostic Model for Clear Cell Renal Cell Carcinoma Based on Tumor Microenvironment.
    Wang M; Song Q; Song Z; Xie Y
    Horm Metab Res; 2023 Jun; 55(6):402-412. PubMed ID: 37192644
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
    Zlotta AR; Ballas LK; Niemierko A; Lajkosz K; Kuk C; Miranda G; Drumm M; Mari A; Thio E; Fleshner NE; Kulkarni GS; Jewett MAS; Bristow RG; Catton C; Berlin A; Sridhar SS; Schuckman A; Feldman AS; Wszolek M; Dahl DM; Lee RJ; Saylor PJ; Michaelson MD; Miyamoto DT; Zietman A; Shipley W; Chung P; Daneshmand S; Efstathiou JA
    Lancet Oncol; 2023 Jun; 24(6):669-681. PubMed ID: 37187202
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Using machine learning to predict lymph node metastasis in patients with renal cell carcinoma: A population-based study.
    Zhang Y; Yi X; Tang Z; Xie P; Yin N; Deng Q; Zhu L; Luo H; Peng K
    Front Public Health; 2023; 11():1104931. PubMed ID: 37033061
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis.
    Allen I; Hassan H; Sofianopoulou E; Eccles D; Turnbull C; Tischkowitz M; Pharoah P; Antoniou AC
    Breast Cancer Res; 2023 Feb; 25(1):18. PubMed ID: 36765408
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adoption of Innovative Therapies Across Oncology Practices-Evidence From Immunotherapy.
    Carroll CE; Landrum MB; Wright AA; Keating NL
    JAMA Oncol; 2023 Mar; 9(3):324-333. PubMed ID: 36602811
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Head-to-head comparison of [
    Wang G; Li L; Wang J; Zang J; Chen J; Xiao Y; Fan X; Zhu L; Kung HF; Zhu Z
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1499-1509. PubMed ID: 36600099
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection.
    Sun F; Li Z; Hu L; Deng W; Jiang T; Wang S; Bi X; Lu H; Yang L; Lin Y; Zeng Z; Shen G; Liu R; Chang M; Wu S; Gao Y; Hao H; Xu M; Chen X; Zhang L; Lu Y; Dong J; Xie Y; Li M
    Front Immunol; 2022; 13():1082091. PubMed ID: 36505492
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association Between Glycemic Status and the Risk of kidney Cancer in Men and Women: A Nationwide Cohort Study.
    Park JH; Hong JY; Han K; Shen JJ
    Diabetes Care; 2023 Jan; 46(1):38-45. PubMed ID: 36350087
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
    Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
    Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incidence and outcome of patients with renal cell carcinoma treated with partial or radical nephrectomy in the Cantons St Gallen and Appenzell 2009-2018.
    Aeppli S; Engeler DS; Fischer S; Omlin A; Pratsinis M; Hermann C; Rothermundt C
    Swiss Med Wkly; 2022 Jun; 152():w30175. PubMed ID: 35752957
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Does size matter? Comparing robotic versus open radical nephrectomy for very large renal masses.
    Pahouja G; Sweigert SE; Sweigert PJ; Gorbonos A; Patel HD; Gupta GN
    Urol Oncol; 2022 Oct; 40(10):456.e1-456.e7. PubMed ID: 35667982
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers.
    Liu Z; Lin C; Suo C; Zhao R; Jin L; Zhang T; Chen X
    Metabolism; 2022 Feb; 127():154955. PubMed ID: 34915036
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.